Raikhan Temirkhanova

Raikhan Temirkhanova


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
ZMZhazira Mansharipova
Zhazira Mansharipova
ATAssiya Turgambayeva
Assiya Turgambayeva
BTBakytkul Toktabayeva
Bakytkul Toktabayeva
AAAizhan Abylgazinova
Aizhan Abylgazinova
GKGulnara Kapanova
Gulnara Kapanova
AMAkmaral Mussakhanova
Akmaral Mussakhanova
Background/Objectives: Newly registered autism spectrum disorder (ASD) cases in Kazakhstan have increased, but population-standardized regional variation and its relation to child psychiatry workforce capacity have not been described. Methods: This retrospective ecological study used annual psychiatric service reports (Form 10-f, Ministry of Health) for 2015–2025, including newly registered cases coded F84.0, F84.1 and F84.5 among children aged 0–17 years. Rates per 100,000 children were calculated nationally and for 16 historical-boundary regions. The national trend was modeled using negative binomial regression and regional inequality using the Gini coefficient. Results: The national rate of newly registered ASD cases increased from 3.9 to 63.5 per 100,000 children (average annual rate ratio 1.32, 95% CI 1.31–1.34), whereas child psychiatrist density declined from 2.06 to 1.43 per 100,000 children and the ratio of newly registered cases to child psychiatrists increased from 1.9 to 44.3. In 2025, regional rates ranged from 28.7 to 221.4 (Astana) per 100,000 children. The Gini coefficient of regional rates decreased from 0.64 to 0.32. Conclusions: Registered ASD cases increased markedly while child psychiatrist density declined, and registration rates varied substantially between regions. These data describe registration rather than prevalence, and regional estimates are subject to uncertainty in population denominators.

AMAssylzhan Messova
Assylzhan Messova
MSMakhmutbay Sanbayev
Makhmutbay Sanbayev
SASagira Abdrakhmanova
Sagira Abdrakhmanova
RTRaikhan Temirkhanova
Raikhan Temirkhanova
NMNadiar Maratovich Mussin
Nadiar Maratovich Mussin
Amin TamadonAmin Tamadon
Amin Tamadon
Background/Objectives: Autoimmune and immune-mediated adverse events coded in reports listing COVID-19 vaccines as suspect products are rare, heterogeneous, and difficult to evaluate in spontaneous reporting systems. We characterized autoimmune reporting signals using strict case definitions and an active-comparator disproportionality design. Methods: FAERS reports from 2021Q1 to 2023Q4 were deduplicated and harmonized by vaccine product, platform, sex, age group, and MedDRA Preferred Term (PT). COVID-19 vaccine reports recorded as primary or secondary suspect products were compared with traditional non-COVID vaccine reports. Strict autoimmune events were grouped into neurological, endocrine, rheumatological, hematological, dermatological, and cardiac categories. Reporting odds ratios (RORs), proportional reporting ratios (PRRs), PT-level rankings, masking audits, and sensitivity analyses were evaluated. Results: The primary analysis included 4191 COVID-19 vaccine reports, 2817 comparator reports, and 311 strict-autoimmune reports contributing 316 report-category observations. Positive category-level signals were identified for dermatological (ROR 10.49; 95% CI: 2.51–43.86), endocrine (ROR 5.39; 95% CI: 1.24–23.48), hematological (ROR 4.68; 95% CI: 2.32–9.44), and neurological events (ROR 1.63; 95% CI: 1.16–2.29). Rheumatological reporting was lower, strict cardiac events were absent, and hematological signals were most consistent across sensitivity analyses. Among five adjusted-positive finite PT signals, immune thrombocytopenia was more stable, multiple sclerosis intermediate, and acquired hemophilia, myasthenia gravis, and optic neuritis sparse/imprecise. A post hoc audit identified four potential clusters among 20 acquired-hemophilia reports; cluster collapse reduced the ROR to 2.70 (95% CI 0.30–24.18; p = 0.654). Conclusions: These findings are hypothesis-generating and do not establish incidence, absolute risk, or causality.